HEM Pharma, Inc. engages in the provision of microbiome solutions. Its products and services include customized healthcare and live biotherapeutic products (LBP) discovery platform services, myLAB, phytobiome, technology transfer, microbiome analysis, and phytochemical solutions. The company was founded on December 30, 2016 and is headquartered in Pohang-si, South Korea.